A simple phenotypic method for the differentiation of metallo-β-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 8, 2010, Pages 1664-1671

  Tsakris, Athanassios ^a   Poulou, Aggeliki ^a,b   Pournaras, Spyros ^c   Voulgari, Evangelia ^a   Vrioni, Georgia ^a   Themeli Digalaki, Katerina ^d   Petropoulou, Dimitra ^e   Sofianou, Danai ^f  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b General District Hospital of Serres   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

^d TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^e Saint Panteleimon Hospital   (Greece)

^f Aristotle University of Thessaloniki   (Greece)

Author keywords

Boronic acid; Class A carbapenemases; Combined disc test; EDTA; Extended spectrum lactamases; MBLs; Plasmid mediated AmpC

Indexed keywords

BENZENEBORONIC ACID; BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CARBAPENEMASE; CLAVULANIC ACID; EDETIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; ENTEROBACTER; ENTEROBACTERIACEAE; ENZYME INHIBITION; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENOTYPE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; SERRATIA MARCESCENS; SPECIES IDENTIFICATION; BIOSYNTHESIS; CLASSIFICATION; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; EVALUATION STUDY; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

EID: 77954694549     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq210     Document Type: Article

References (30)

1. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440-58.
2. VIM-1 metallo-β-lactamase gene. J Clin Microbiol 2005; 43: 5344-7.
3. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-36.
4. Yigit H, Queenan AM, Anderson GJ et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 1151-61.
5. Bratu S, Landman D, Haag R et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005; 165: 1430-5.
6. Cai JC, Zhou HW, Zhang R et al. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008; 52: 2014-8.
7. KPC-2 carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob Agents Chemother 2008; 52: 2962-5.
8. KPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009; 64: 1102-10.
9. Kitchel B, Rasheed JK, Patel JB et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae in the United States: clonal expansion of MLST sequence type 258. Antimicrob Agents Chemother 2009; 53: 3365-70.
10. Pournaras S, Protonotariou E, Voulgari E et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009; 64: 348-52.
11. Giakkoupi P, Pappa O, Polemis M et al. Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases. Antimicrob Agents Chemother 2009; 53: 4048-50.
12. KPC gene. Antimicrob Agents Chemother 2008; 52: 1257-63.
13. Rasheed JK, Biddle JW, Anderson KF et al. Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol 2008; 46: 2066-9.
14. Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-β-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol 2006; 44: 3139-44.
15. Doi Y, Potoski BA, Adams-Haduch JM et al. Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type β-lactamase by use of a boronic acid compound. J Clin Microbiol 2008; 46: 4083-6.
16. Pasteran F, Mendez T, Guerriero L et al. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol 2009; 47: 1631-9.
17. Tsakris A, Kristo I, Poulou A et al. Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. J Clin Microbiol 2009; 47: 362-7.
18. Moland ES, Hanson ND, Herrera VL et al. Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother 2003; 51: 711-4.
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
20. Song W, Bae IK, Lee YN et al. Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 2007; 45: 1180-4.
21. Tsakris A, Poulou A, Themeli-Digalaki K et al. Use of boronic acid disk tests to detect extended-spectrum β-lactamases in clinical isolates of KPC carbapenemase-possessing Enterobacteriaceae. J Clin Microbiol 2009; 47: 3420-6.
22. Poirel L, Héritier C, Tolün V et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48: 15-22.
23. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
24. Tzelepi E, Magana C, Platsouka E et al. Extended-spectrum β-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int J Antimicrob Agents 2003; 21: 285-8.
25. Preston KE, Radomski CC, Venezia RA. Nucleotide sequence of the chromosomal ampC gene of Enterobacter aerogenes. Antimicrob Agents Chemother 2000; 44: 3158-62.
26. Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005; 43: 4163-7.
27. KPC in the United States. Antimicrob Agents Chemother 2008; 52: 2680-2.
28. Tsakris A, Kristo I, Poulou A et al. First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J Antimicrob Chemother 2008; 62: 1257-60.
29. Anderson KF, Lonsway DR, Rasheed JK et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007; 45: 2723-5.
30. Doi Y, Paterson DL. Detection of plasmid-mediated class C β-lactamases. Int J Infect Dis 2007; 11: 191-7.